NASDAQ:SCNI | Free Cash Flow | Scinai Immunotherapeutics Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2023-03-31-$3.06M$6,000.00-$3.07M
2022-03-31-$1.11M$521,000.00-$1.63M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.03M$24,000.00-$6.06M
2024-12-31-$6.34M$12,000.00-$6.35M-132.34%
2023-12-31-$9.38M$637,000.00-$10.02M
2022-12-31-$7.27M$836,000.00-$8.1M
2021-12-31-$7.43M$139,000.00-$7.57M